InVitria
the global leader in chemically-defined animal-origin-free recombinant proteins for biologics manufacturing, with an ISO 9001:2015-certified cGMP facility; its rice-based ExpressTec platform is the first plant-based recombinant expression system to support an FDA-, EMA-, and PMDA-approved injectable biologic;…
- Country
- United States
Exbumin excipient in Merck ERVEBO Ebola vaccine since 2019 (250,000+ injections); Optibumin 25 launched Apr 29, 2025
us
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| specialty-fine-chem | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Recombinant human serum albumin (rHSA) | specialty-fine-chem | Low | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.